O'Halloran Katrina, Ritchey A Kim, Djokic Miroslav, Friehling Erika
Department of Pediatrics Residency Program, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania.
Division of Hematology/Oncology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania.
Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26408. Epub 2017 Jan 13.
Juvenile myelomonocytic leukemia (JMML) is a rare childhood neoplasm with poor prognosis except in the setting of Noonan syndrome, where prognosis is generally favorable. We present the case of a child with JMML in the setting of germline PTPN11 mutation and Noonan syndrome with suspected secondary development of monosomy 7 in the bone marrow. Diagnosed shortly after birth, she has been managed with active surveillance alone. Myeloblast percentages initially fluctuated; however, bone marrow biopsy at 4 years of age showed spontaneous remission despite persistence of the monosomy 7 clone, supporting a cautious approach in similar cases.
青少年粒单核细胞白血病(JMML)是一种罕见的儿童肿瘤,预后较差,除非是在努南综合征的情况下,其预后通常较好。我们报告了一例患有JMML的儿童病例,该儿童存在种系PTPN11突变,并患有努南综合征,骨髓中疑似继发7号染色体单体。她在出生后不久被诊断出,一直仅接受主动监测。原始粒细胞百分比最初有波动;然而,4岁时的骨髓活检显示尽管7号染色体单体克隆持续存在,但出现了自发缓解,这支持了对类似病例采取谨慎的处理方法。